Original Research
Published on 05 Mar 2025
Research on the impact of tourism cooperation on urban public health
in Health Economics
Frontiers in Public Health
doi 10.3389/fpubh.2025.1556789
Type at least 3 characters
1,503 articles
Articles
Original Research
Accepted on 04 Mar 2025
Analysis of Trends in the Burden of Colorectal Cancer in China and Globally from 1990 to 2021 with Projections for the Next 15 Years: A Cross-Sectional Study Based on the GBD Database
in Health Economics
Frontiers in Public Health
doi 10.3389/fpubh.2025.1518536
Original Research
Published on 04 Mar 2025
Promoting Healthy Aging: Physical Activity and Its Dual Effects on Physical Health and Cognitive Function in Chinese Older Adults
in Health Economics
Frontiers in Public Health
doi 10.3389/fpubh.2025.1561060
- 231 views
Original Research
Published on 04 Mar 2025
Disparities of healthcare utilization in sexually transmitted diseases management: focusing on racial/regional variances with U.S. national inpatient sample in 2016–2019
in Health Economics
Frontiers in Public Health
doi 10.3389/fpubh.2025.1543117
- 232 views
Original Research
Accepted on 03 Mar 2025
A Cost Analysis of Reductions in Work Productivity for MG Patients and their Caregivers by Symptom Severity
in Health Economics
Frontiers in Public Health
doi 10.3389/fpubh.2025.1538789
Original Research
Accepted on 03 Mar 2025
Socioeconomic inequality of financial hardship to access quality healthcare services in Ethiopia: A Community based cross-sectional study
in Health Economics
Frontiers in Public Health
doi 10.3389/fpubh.2025.1484671
Original Research
Published on 03 Mar 2025
Influencing factors of hospitalization costs for intensive rehabilitation in patients with post-stroke disorder of consciousness
in Health Economics
Frontiers in Public Health
doi 10.3389/fpubh.2025.1552148
- 214 views
Original Research
Published on 28 Feb 2025
Time trends in stomach cancer mortality across the BRICS: an age-period-cohort analysis for the GBD 2021
in Health Economics
Frontiers in Public Health
doi 10.3389/fpubh.2025.1506925
- 177 views
Original Research
Accepted on 26 Feb 2025
Research on the Evolution of Biotechnology Cooperation Networks -A Study Based on Patent Data in China from 2004 to 2023
in Health Economics
Frontiers in Public Health
doi 10.3389/fpubh.2025.1437212
Original Research
Accepted on 26 Feb 2025
Direct economic burden of Acute Coronary Syndromes (ACS) in the Portuguese National Health Service -facts and trends between 2002 and 2022
in Health Economics
Frontiers in Public Health
doi 10.3389/fpubh.2025.1433307
Original Research
Published on 26 Feb 2025
Global, regional and national burden of decubitus ulcers in 204 countries and territories from 1990 to 2021: a systematic analysis based on the global burden of disease study 2021
in Health Economics
Frontiers in Public Health
doi 10.3389/fpubh.2025.1494229
- 261 views
Original Research
Published on 26 Feb 2025
Examining how fiscal policies influence innovation in TCM enterprises: the role of R&D investment and executives with pharmaceutical backgrounds
in Health Economics
Frontiers in Public Health
doi 10.3389/fpubh.2025.1531622
- 223 views
Original Research
Published on 25 Feb 2025
Economic burden of antimicrobial resistance on patients in Pakistan
in Health Economics
Frontiers in Public Health
doi 10.3389/fpubh.2025.1481212
- 414 views
Hypothesis and Theory
Accepted on 24 Feb 2025
Conceptually mapping how investing in essential public health functions (EPHFs) and common goods for health (CGH) can improve health system performance
in Health Economics
Frontiers in Public Health
doi 10.3389/fpubh.2025.1531837
Original Research
Accepted on 24 Feb 2025
In-patient Expenditure Between 2011 and 2021 for Patients With Type 2 diabetes mellitus: A Hospital-Based Multicenter Retrospective Study in Southwest China
in Health Economics
Frontiers in Public Health
doi 10.3389/fpubh.2025.1559424
Hypothesis and Theory
Accepted on 24 Feb 2025
The impact of artificial intelligence on sustainable development performance of public healthcare supply chain-An empirical study based on listed Chinese pharmaceutical companies
in Health Economics
Frontiers in Public Health
doi 10.3389/fpubh.2025.1549283